Nanoparticle-mediated p53 gene therapy for tumor inhibition

Author： Sharma Blanka  

Publisher： Springer Publishing Company

ISSN： 2190-393X

Source： Drug Delivery and Translational Research, Vol.1, Iss.1, 2011-02, pp. : 43-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoparticle-mediated delivery of RNA in tumor therapy

By Aigner Achim   Fischer Dagmar  

PHARMAKON, Vol. 3, Iss. 4, 2015-07 ,pp. : 284-292

Govi-Verlag

Access to resources Recommend Favorite

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

By Aigner A.   Fischer D.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 71, Iss. 1, 2016-01 ,pp. : 27-34

Govi-Verlag

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

A UVB Fingerprint Mutation on the p53 Tumor Suppressor Gene Decreases in vitro

By  

Cells Tissues Organs, Vol. 188, Iss. 3, 2008-03 ,pp. : 280-286

Karger

Access to resources Recommend Favorite

Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3248-3262

Bentham Science Publishers

Access to resources Recommend Favorite